Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
arterial occlusive diseases
MeSH D001157 - arterial occlusive diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014652:
Vascular diseases
1 Company
1 Drug
$
Success rate
D001157:
Arterial occlusive diseases
1 Company
1 Drug
$
Success rate
D000071079:
Pulmonary artery stenosis
0 Companies
0 Drugs
Success rate
D000074742:
Median arcuate ligament syndrome
0 Companies
0 Drugs
Success rate
D000083082:
Popliteal artery entrapment syndrome
0 Companies
0 Drugs
Success rate
D001161:
Arteriosclerosis
5 Companies
1 Drug
$
Success rate
D005352:
Fibromuscular dysplasia
0 Companies
0 Drugs
Success rate
D007925:
Leriche syndrome
0 Companies
0 Drugs
Success rate
D008641:
Mesenteric vascular occlusion
0 Companies
0 Drugs
Success rate
D009072:
Moyamoya disease
0 Companies
0 Drugs
Success rate
D012078:
Renal artery obstruction
0 Companies
0 Drugs
Success rate
D013919:
Thromboangiitis obliterans
1 Company
1 Drug
$
Success rate
D015356:
Retinal artery occlusion
0 Companies
0 Drugs
Success rate
D016893:
Carotid stenosis
0 Companies
0 Drugs
Success rate
D054853:
Malignant atrophic papulosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Genentech
Alteplase
Cathflo Activase
1987-11-13
Clinical Trials
Historical Success Rate
Phase 1
100
%
3/3
Phase 2
56
%
5/9
Phase 3
19
%
5/26
Approved:
2
Overall Success rate:
11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Genentech
Alteplase
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use